“The ASA considered that the advertorial misleadingly implied adequate objective evidence existed to substantiate claims that LadyCare could contribute to relieving the symptoms of menopause. The ASA considered the advertorial was misleading because we had not seen evidence that demonstrated the efficacy of the LadyCare product in relieving the menopause or symptoms of menopause.”